1. Prominent role of cyclic adenosine monophosphate signalling pathway in the sensitivity of WTBRAF/WTNRAS melanoma cells to vemurafenib
   Mohammad Krayem et al, 2014, European Journal of Cancer CrossRef
2. Molecular Pathways: Adaptive Kinome Reprogramming in Response to Targeted Inhibition of the BRAF–MEK–ERK Pathway in Cancer
   Gary L. Johnson et al, 2014, Clinical Cancer Research CrossRef
3. STAT3 Inhibitors in Cancer: A Comprehensive Update
   Uddalak Bharadwaj et al, 2016, STAT Inhibitors in Cancer CrossRef
4. Mechanism-based cancer therapy: resistance to therapy, therapy for resistance
   P Ramos et al, 2015, Oncogene CrossRef
5. Lentiginoses in polycythemia vera patient: Is there a role forJAK2 (V617F)mutation?
   Tugba Kevser Uzuncakmak et al, 2015, JAK-STAT CrossRef